SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-076183
Filing Date
2024-06-21
Accepted
2024-06-21 16:00:04
Documents
1
Period of Report
2024-06-20

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3885
  Complete submission text file 0000950170-24-076183.txt   5417
Mailing Address C/O INTERCEPT PHARMACEUTICALS, INC. 18 DESBROSSES ST. NEW YORK NY 10013
Business Address
Shapiro David (Reporting) CIK: 0001559570 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39655 | Film No.: 241060038

Mailing Address 75 STATE STREET SUITE 100 BOSTON MA 02109
Business Address 75 STATE STREET SUITE 100 BOSTON MA 02109 45-70-70-52-10
Galecto, Inc. (Issuer) CIK: 0001800315 (see all company filings)

IRS No.: 371957007 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)